Caption Management’s CVS Health CVS Stock Holding History

Caption Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-42,000	Closed	-$3.75M	–	1740
2026 Q1	$3.02M	Buy	+42,000	New	+$3.24M	0.02%	690
2025 Q4	–	Sell	-47,000	Closed	-$3.71M	–	1662
2025 Q3	$3.54M	Sell	47,000 -33,000	-41%	-$2.26M	0.03%	615
2025 Q2	$5.52M	Buy	+80,000	New	+$5.25M	0.06%	379
2025 Q1	–	Sell	-74,000	Closed	-$4.43M	–	1623
2024 Q4	$3.32M	Buy	+74,000	New	+$4.15M	0.03%	520
2023 Q2	–	Sell	-37,200	Closed	-$2.65M	–	1160
2023 Q1	$2.76M	Sell	37,200 -16,800	-31%	-$1.41M	0.05%	369
2022 Q4	$5.03M	Buy	54,000 +42,000	+350%	+$4.05M	0.08%	303
2022 Q3	$1.15M	Buy	+12,000	New	+$1.19M	0.02%	823
2022 Q2	–	Sell	-108,500	Closed	-$10.6M	–	1510
2022 Q1	$11M	Buy	+108,500	New	+$11.4M	0.13%	192
2019 Q1	–	Sell	-49,000	Closed	-$3.21M	–	599
2018 Q4	$3.21M	Buy	49,000 +12,000	+32%	+$896K	0.26%	119
2018 Q3	$2.91M	Buy	+37,000	New	+$2.65M	0.16%	175

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Caption Management's CVS Position: Q2 2026 in Review

Caption Management sold out of CVS Health (CVS) in Q2 2026, closing a stake of 42,000 shares — an estimated $3.75M sold.

Caption Management first reported a position in CVS in Q3 2018 and held it in 10 quarters. The position peaked at $11M in Q1 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Caption Management reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
Caption Management sold 42,000 CVS Health shares in Q2 2026, an estimated $3.75M.
Caption Management first reported a position in CVS Health in Q3 2018 and held it in 10 quarters.
Caption Management's CVS Health position peaked at $11M in Q1 2022.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.